Acitretin, known for its anti-tumor proliferation effect, especially in UV-induced carcinogenesis and successful use in cutaneous CD30-positive anaplastic large cell lymphoma,6 was our first therapeutic choice deemed suitable in the treatment of our patient. This evidence concerns the gene TNFRSF8 and neoplasm.